Table 1. Demography and clinical characteristics of patients in the study.
Patient # | Age | Gender | Race | OS(M) | KPS | Protein | LDH |
1 | 67 | M | C | 23 | 80 | 128 | 158 |
2 | 46 | F | C | 150 | 421 | ||
3 | 45 | F | C | 155 | 70 | 63 | 534 |
4 | 71 | F | C | 58 | |||
5 | 66 | F | C | 1 | 138 | ||
6 | 65 | F | C | 5 | 70 | 76 | 245 |
7 | 43 | F | C | 4 | 100 | 30 | |
8 | 54 | F | C | 6 | 50 | 60 | 148 |
9 | 64 | M | C | 74 | 80 | ||
10 | 65 | M | C | 27 | |||
11 | 90 | F | C | ||||
12 | 72 | M | C | 5 | |||
13 | 78 | M | C | 62 | |||
14 | 64 | F | C | ||||
15 | 64 | M | C | ||||
16 | 71 | M | C | 5 | |||
17 | 82 | F | C | 5 | |||
18 | 30 | M | C | 19 | |||
19 | 63 | M | C | 19 | |||
20 | 72 | F | C | 2 | |||
21 | 65 | M | C |
OS(M): overall survival in months; KPS: Karnofsky performance score; LDH: lactate dehydrogenase; M: male; F: female; Protein: cerebrospinal fluid protein; C: Caucasian |